Active Ingredient History
Adalimumab, sold under the brand name Humira, among others, is a monoclonal antibody used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, uveitis, and juvenile idiopathic arthritis. It is administered by injection under the skin. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Adalimumab (Phase 4)
Arthritis (Phase 4)
Arthritis, Juvenile (Phase 3)
Asians (Phase 3)
Asthma (Phase 2)
Autoimmune Diseases (Phase 2)
Axial Spondyloarthritis (Phase 4)
Biological Therapy (Phase 2)
Cardiovascular Diseases (Phase 4)
Choroidal Neovascularization (Phase 2)
Colitis (Phase 2)
Coronary Artery Disease (Phase 4)
COVID-19 (Phase 3)
Crohn Disease (Phase 4)
Cystitis, Interstitial (Phase 3)
Cytokines (Phase 2)
Diabetes Mellitus, Type 2 (Phase 4)
Diabetic Retinopathy (Phase 1)
Drug Evaluation (Phase 2)
Drugs, Investigational (Phase 4)
Dupuytren Contracture (Phase 2)
Enterocolitis (Phase 4)
Giant Cell Arteritis (Phase 3)
Glomerulosclerosis, Focal Segmental (Phase 2)
Healthy Volunteers (Phase 1)
Hermanski-Pudlak Syndrome (Phase 2)
Hidradenitis Suppurativa (Phase 4)
Hypertension (Phase 4)
Immune System Diseases (Phase 4)
Immunity, Innate (Early Phase 1)
Inflammation (Phase 4)
Inflammatory Bowel Diseases (Phase 4)
Intestinal Diseases (Phase 4)
Intestinal Neoplasms (Phase 3)
Joint Diseases (Phase 4)
Lymphocytes (Phase 2)
Macular Degeneration (Phase 2)
Methotrexate (Phase 4)
Mucopolysaccharidosis I (Phase 2/Phase 3)
Mucopolysaccharidosis II (Phase 2/Phase 3)
Mucopolysaccharidosis VI (Phase 2/Phase 3)
Musculoskeletal Diseases (Phase 4)
Myocardium (Phase 4)
Nephrosis, Lipoid (Phase 2)
Netherton Syndrome (Phase 2)
Osteoarthritis (Phase 2)
Osteoarthritis, Knee (Phase 3)
Pain (Phase 3)
Pouchitis (Phase 3)
Psoriasis ()
Pyoderma Gangrenosum (Phase 3)
Sarcoidosis (Phase 2)
Sciatica (Phase 2)
Sleep Apnea, Obstructive (Phase 4)
Spinal Diseases (Phase 3)
Spondylarthropathies (Phase 4)
Substance Withdrawal Syndrome (Phase 3)
Takayasu Arteritis (Phase 4)
Therapeutic Equivalency (Phase 1)
Therapeutics (Phase 4)
Thyroid Carcinoma, Anaplastic (Phase 1)
Ultrasonography (Phase 4)
Uveitis (Phase 4)
Uveitis, Anterior (Phase 4)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
